Business Consultant

COVID-19 crisis can prove to be a catalyst for Artificial Intelligence in Healthcare

Articles, Business Consultant, Pharma Consultant

The novel coronavirus (COVID-19) within a span of five months, has infected around 1 million people, resulting in deaths of 50,000 people...

Read More

Immunomedics Halts Sacituzumab govitecan trial; GSK-Vir Biotech collaboration; INO-4800 DNA COVID-19 Vaccine; Pfizer Commits $ 40M for COVID-19;

Business Consultant, News, Pharma Consultant

Immunomedics discontinues its trial early – hopes for accelerated approval of Sacituzumab govitecan for mTNBC Immunomedics– a New...

Read More

Warm Autoimmune Hemolytic Anemia: A less prevalent disease with prevailing unmet needs

Articles, Business Consultant, Pharma Consultant

Warm Autoimmune Hemolytic Anemia market is anticipated to increase with a CAGR of 15.9% in the 7MM by 2030, estimates DelveInsight. In...

Read More

Warm Autoimmune Hemolytic Anemia Epidemiology forecast segmentation, treatment approaches, and WAIHA market forecast

Articles, Business Consultant, Pharma Consultant

As per DelveInsight’s Warm Autoimmune Hemolytic anemia Epidemiology forecast and analysis, WAIHA prevalence in the 7MM was estimated to...

Read More

Telemedicine: Can it be the future of healthcare?

Articles, Business Consultant, Pharma Consultant

Telemedicine is one of the fastest-growing domains in the healthcare industry. Telemedicine is the practice of providing healthcare...

Read More

J&J’s COVID-19 Vaccine; GigaGen COVID-19 therapy; FDA approved Abbott’s POC test; Cobra Bio raises $ 3.3 M;

Business Consultant, News, Pharma Consultant

Johnson & Johnson is fast-forwarding its vaccine development program for COVID-19.  The healthcare company has selected a lead...

Read More
Close